How much funding has Crinetics raised?

Crinetics has raised $103.5M in total funding, most recently a Series B round.

Who are Crinetics's investors?

Crinetics's investors include 5AM Ventures, Vertex Pharmaceuticals, Jerel Davis, Vivo Capital.

Where is Crinetics headquartered?

Crinetics is headquartered in San Diego.

How many employees does Crinetics have?

Crinetics has 501-1000 employees.

Crinetics

IPO

Driving the Next Generation of Endocrinology Care

San Diego · Founded 2008 · $103.5M raised

Biotech

Headquarters: San Diego
Employees: 501–1000
Founded: 2008
Business Model: B2B

Total Funding: $103.5M
Last Round: $63.5M Series BJan 2018
Rounds: 2

About

Crinetics is a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine disease and endocrine-related tumors, including neuroendocrine tumors. Founded by scientists with a track record in GPCR drug discovery, the company built an in-house R&D team pursuing oral small molecule therapies with the mission of becoming the world's leading endocrine company and helping patients better control their disease and improve their daily lives.

Summary

Crinetics is a Biotech company based in San Diego, founded in 2008. It has raised $103.5M in total across 2 rounds, most recently a $63.5M Series B round in Jan 2018. Investors include 5AM Ventures, Vertex Pharmaceuticals and Jerel Davis.

X (Twitter)